SCHEMBL17016124

SCHEMBL17016124

c1ccc(-n2c3ccccc3c3ccc4c(ccn4-c4ccc5c6ccccc6c6ccccc6c5c4)c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ MAPK1 P28482 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ KMT2A Q03164 3/20 0.31
▸ MAPK8 P45983 2/20 0.31
▸ IL1R1 P14778 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPK9 P45984 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ DUSP3 P51452 1/20 0.31
▸ RORC P51449 1/20 0.30
▸ ALKBH5 Q6P6C2 1/20 0.30
▸ FTO Q9C0B1 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015177 0.94 KDM4E (0.42) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL15802433 0.94 KDM4E (0.50) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL17016126 0.93 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL15632115 0.91 KDM4E (0.52) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL15632236 0.91 L3MBTL1 (0.46) L3MBTL1KDM4EATMPGRKMT2A
SCHEMBL16357559 0.90 KDM4E (0.49) L3MBTL1KDM4EATMPGRKMT2A
SCHEMBL15802246 0.90 KDM4E (0.49) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL15802185 0.90 KDM4E (0.55) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL16357549 0.90 KDM4E (0.55) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL15801725 0.90 KDM4E (0.55) L3MBTL1KDM4EATMMAPK1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 L3MBTL1 533/4885KDM4E 1286/4885ATM 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback